BIOMAT Database Logo BIOMAT Database Logo

[Pituitary apoplexy and SARS-CoV-2 (COVID-19) infection]. 2023

Mauro Ruella, and Guido Caffaratti, and Débora Katz, and Ricardo Marengo, and Andrés Cervio
Departamento de Neurocirugía, FLENI, Buenos Aires, Argentina. E-mail: mauro.r_09@hotmail.com.

Coronavirus disease (SARS-CoV-2/COVID-19) is responsible for a wide variety of extrapulmonary manifestations, among which direct or indirect neurological compromise stands out. Pituitary apoplexy is a clinical and neurosurgical entity of variable severity, usually associated with a pituitary adenoma. Literature is scarce regarding the association between these diseases. This paper reports a case of pituitary apoplexy, manifested concomitantly to the diagnosis of COVID 19 in a patient with unknown pituitary macroadenoma, and its therapeutic management, reviewing the mechanisms potentially underlying the link between both entities.

UI MeSH Term Description Entries
D010899 Pituitary Apoplexy The sudden loss of blood supply to the PITUITARY GLAND, leading to tissue NECROSIS and loss of function (PANHYPOPITUITARISM). The most common cause is hemorrhage or INFARCTION of a PITUITARY ADENOMA. It can also result from acute hemorrhage into SELLA TURCICA due to HEAD TRAUMA; INTRACRANIAL HYPERTENSION; or other acute effects of central nervous system hemorrhage. Clinical signs include severe HEADACHE; HYPOTENSION; bilateral visual disturbances; UNCONSCIOUSNESS; and COMA. Apoplexy, Pituitary
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas

Related Publications

Mauro Ruella, and Guido Caffaratti, and Débora Katz, and Ricardo Marengo, and Andrés Cervio
SARS-Cov-2 Infection: A New Risk Factor for Pituitary Apoplexy?
April 2024, Endocrine, metabolic & immune disorders drug targets,
Mauro Ruella, and Guido Caffaratti, and Débora Katz, and Ricardo Marengo, and Andrés Cervio
Eruptive pseudoangiomatosis and SARS-CoV-2 (COVID-19) infection.
August 2021, International journal of dermatology,
Mauro Ruella, and Guido Caffaratti, and Débora Katz, and Ricardo Marengo, and Andrés Cervio
[Epidemiology of SARS-CoV-2 infection and COVID-19].
August 2020, Der Internist,
Mauro Ruella, and Guido Caffaratti, and Débora Katz, and Ricardo Marengo, and Andrés Cervio
SARS-CoV-2 Infection and COVID-19 in Children.
June 2023, Clinics in chest medicine,
Mauro Ruella, and Guido Caffaratti, and Débora Katz, and Ricardo Marengo, and Andrés Cervio
Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).
January 2020, Travel medicine and infectious disease,
Mauro Ruella, and Guido Caffaratti, and Débora Katz, and Ricardo Marengo, and Andrés Cervio
A Rare Case of SARS-CoV-2 Infection Associated With Pituitary Apoplexy Without Comorbidities.
March 2021, Journal of the Endocrine Society,
Mauro Ruella, and Guido Caffaratti, and Débora Katz, and Ricardo Marengo, and Andrés Cervio
Pituitary apoplexy and SARS-CoV-2 infection: we need to look beyond the acute phase.
November 2022, European journal of endocrinology,
Mauro Ruella, and Guido Caffaratti, and Débora Katz, and Ricardo Marengo, and Andrés Cervio
Pituitary Apoplexy in a Child with Short Stature and Possible Recent SARS-CoV-2 Infection.
June 2025, Diagnostics (Basel, Switzerland),
Mauro Ruella, and Guido Caffaratti, and Débora Katz, and Ricardo Marengo, and Andrés Cervio
Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).
July 2020, American journal of hematology,
Mauro Ruella, and Guido Caffaratti, and Débora Katz, and Ricardo Marengo, and Andrés Cervio
Potential repurposed SARS-CoV-2 (COVID-19) infection drugs.
July 2020, RSC advances,
Copied contents to your clipboard!